Horizon agrees licensing deal over anti-inflammatory drug

18-09-2015

Horizon agrees licensing deal over anti-inflammatory drug

Shai_Halud / Shutterstock.com

Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid (diclofenac sodium topical solution).


Horizon Pharma, patent, licensing, Taro Pharmaceutical Industries, Pennsaid, patent licensing

LSIPR